Venetoclax: an unmet need in R/R mantle cell lymphoma after BTK inhibitors VJHemOnc – Video Journal of Hematology & HemOnc 3:27 5 years ago 211 Скачать Далее
The role of venetoclax in R/R MCL & options for patients who progress on venetoclax VJHemOnc – Video Journal of Hematology & HemOnc 2:06 1 year ago 123 Скачать Далее
Dr. Eyre on BTK Inhibitors in Combination With Venetoclax for MCL OncLive 1:52 5 years ago 168 Скачать Далее
Unmet Needs and Future of R/R Mantle Cell Lymphoma Targeted Oncology 2:31 4 years ago 49 Скачать Далее
BTK inhibitors for R/R MCL: current uses and insights from the ViPOR study VJHemOnc – Video Journal of Hematology & HemOnc 2:40 1 year ago 126 Скачать Далее
Treating CLL after venetoclax or BTK inhibitors VJHemOnc – Video Journal of Hematology & HemOnc 1:42 2 years ago 681 Скачать Далее
Dr. Ritchie on the Immunologic Impact of Long-Term Venetoclax/Ibrutinib in R/R MCL OncLive 1:09 4 years ago 54 Скачать Далее
Dr. Ritchie on Immunological Response to Venetoclax/Ibrutinib in R/R MCL OncLive 1:27 4 years ago 142 Скачать Далее
Improvements and remaining challenges in treating R/R MCL after failure of BTK inhibitors VJHemOnc – Video Journal of Hematology & HemOnc 1:57 10 months ago 114 Скачать Далее
Venetoclax and R2 in mantle cell lymphoma VJHemOnc – Video Journal of Hematology & HemOnc 5:50 3 years ago 412 Скачать Далее
Challenges in using CAR-T therapy & BTK inhibitors in patients with R/R MCL VJHemOnc – Video Journal of Hematology & HemOnc 1:47 1 year ago 180 Скачать Далее
Selecting BTK inhibitors for patients with MCL VJHemOnc – Video Journal of Hematology & HemOnc 1:32 1 year ago 165 Скачать Далее
Venetoclax, lenalidomide and rituximab in R/R MCL VJHemOnc – Video Journal of Hematology & HemOnc 2:22 3 years ago 66 Скачать Далее
Durable responses to ibrutinib and venetoclax in R/R MCL: 3-year AIM update VJHemOnc – Video Journal of Hematology & HemOnc 3:06 4 years ago 77 Скачать Далее
SYMPATICO: safety and efficacy of ibrutinib plus venetoclax for R/R MCL VJHemOnc – Video Journal of Hematology & HemOnc 3:18 3 years ago 87 Скачать Далее
Venetoclax, lenalidomide + rituximab: a chemotherapy-free regimen for previously untreated MCL VJHemOnc – Video Journal of Hematology & HemOnc 2:50 1 year ago 246 Скачать Далее
What’s New In Mantle Cell Lymphoma: Updates from ASCO 2024 & the EHA Hybrid Congress ExchangeCME 23:10 1 day ago 13 Скачать Далее
Impressive results for R-BAC post BTKi in R/R MCL VJHemOnc – Video Journal of Hematology & HemOnc 1:28 4 years ago 156 Скачать Далее
Toby Eyre | Would venetoclax monotherapy be a good option for R/R MCL post-BTK inhibitor therapy? Lymphoma Hub 2:38 6 years ago 395 Скачать Далее
The safety of venetoclax, ibrutinib, prednisone, obinutuzumab, and lenalidomide (ViPOR) in R/R MCL VJHemOnc – Video Journal of Hematology & HemOnc 1:39 1 year ago 207 Скачать Далее
